Drug ID: | NPD3968 |
Drug Name: | Methotrexate |
Molecular Formula: | C20H22N8O5 |
Canonical SMILES: | CN(c1ccc(cc1)C(=O)N[C@H](C(=O)O)CCC(=O)O)Cc1cnc2c(n1)c(N)[nH]c(=N)n2 |
Standard InCHI: | InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1 |
Standard InCHIKey: | FBOZXECLQNJBKD-ZDUSSCGKSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | ChEMBL; IUPHAR/BPS |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DCL000681; DNC000933 |
DrugBank | DB00563 |
ChEMBL | CHEMBL34259 |
IUPHAR/BPS | 4815 |
PharmaGKB | PA450428 |
KEGG Drug | D00142 |
PubChem CID | 11557063 |
ChEBI | 44185 |
CAS Number | 59-05-2 |
Molecular Weight | 454.17 |
ALogP | -3.1982 |
MLogP | 2.23 |
XLogP | -1.911 |
HDA | 13 |
HBD | 6 |
Rotatable Bonds | 14 |
TPSA | 206.98 |
RO5 Violation | 2 |